These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


60 related items for PubMed ID: 2309002

  • 1. Selective eradication of leukemic (L-CFU) versus normal (CFU-GM) myeloid progenitors in suspension culture utilizing a prolonged exposure to 1-B-D arabinofuranosylcytosine (Ara-C) and deoxycytidine (dCyd).
    Grant S, Howe C, Kuczynski T.
    Prog Clin Biol Res; 1990; 333():69-77. PubMed ID: 2309002
    [No Abstract] [Full Text] [Related]

  • 2. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 3. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
    Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S.
    Blood; 1987 Aug; 70(2):568-71. PubMed ID: 3607288
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia.
    Broughton CM, Sherrington P, Pender NT, Clark RE.
    Genes Chromosomes Cancer; 1997 Apr; 18(4):292-8. PubMed ID: 9087569
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

  • 12. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
    Mihál V, Hajdúch M, Dusek J, Jarosová M, Weigl E, Pikalová Z, Indrák K, Safárová M, Janostáková A.
    Neoplasma; 1997 Aug; 44(2):133-6. PubMed ID: 9201294
    [Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 14. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells].
    He Q, Xu YH.
    Yao Xue Xue Bao; 1996 Nov; 31(5):340-5. PubMed ID: 9275711
    [Abstract] [Full Text] [Related]

  • 15. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 16. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A, Olofsson T.
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [Abstract] [Full Text] [Related]

  • 17. [Effect of 2-chlorodeoxyadenosine, arabinoside cytosine and doxorubicin on acute myeloid leukemia clonogenic cell proliferation].
    Sawiński K, Hansz J, Kozłowska-Skrzypczak M.
    Acta Haematol Pol; 1995 Oct; 26(3):279-84. PubMed ID: 8525773
    [Abstract] [Full Text] [Related]

  • 18. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
    Murphy PB, Richman CM.
    Exp Hematol; 1989 Dec; 17(11):1105-9. PubMed ID: 2583254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.